Do you want to read an article? Please log in or register.
The Impact of IgG Fc-Glycosylation on Disease Dynamics in Primary Sjögren's Disease- Insights from the Belgian Sjögren's Syndrome Transition Trial
Autoimmune Disease
Indications
Related content
Further Publications Immunology
Patients' recollection about the onset of Sjögren's disease - a mixed methods study on the patients' perspective
Arthritis Res Ther
Lackner A, Dreo B, Hermann J, Zenz S, Fessler J, Thiel J, Stradner MH
doi: 10.1186/s13075-024-03404-8
Autoimmune Disease
Safety and efficacy of subcutaneous iscalimab (CFZ533) in two distinct populations of patients with Sjögren's disease (TWINSS): week 24 results of a randomised, double-blind, placebo-controlled, phase 2b dose-ranging study
Lancet
Fisher BA, Mariette X, Papas A, Grader-Beck T, Bootsma H, Ng WF, van Daele PLA, Finzel S, Noaiseh G, Elgueta S, Hermann J, McCoy SS, Akpek E, Bookman A, Sopala M, Montecchi-Palmer M, Luo WL, Scheurer C, Hueber W, TWINSS study group
doi: 10.1016/S0140-6736(24)01211-X
Further Publications Immunology
Efficacy and safety of therapies for Still's disease and macrophage activation syndrome (MAS): a systematic review informing the EULAR/PReS guidelines for the management of Still's disease
Ann Rheum Dis
Bindoli S, De Matteis A, Mitrovic S, Fautrel B, Carmona L, De Benedetti F
doi: 10.1136/ard-2024-225854
Autoimmune Disease
Are ultrasound salivary parenchymal lesions more severe in primary Sjögren patients with a longer disease duration? A cross-sectional study
Rheumatology (Oxford)
Tison A, Jousse-Joulin S, Consigny M, Moog P, Hofauer B, Hachulla E, Lamotte C, Morel J, Mouterde G, Milic V, Bootsma H, Stel A, Fisher BA, Maybury M, Baer A, DiRenzo D, Kim HR, Min HK, Lee SS, Choi SE, Alegria GC, Boisramé S, Guellec D, Cornec D, Quéré B, Jonsson M, Hammenfors D, Saraux A, Devauchelle-Pensec V
doi: 10.1093/rheumatology/keae690
Juvenile Idiopathic Arthritis
Systemic juvenile idiopathic arthritis and adult-onset Still's disease are the same disease: evidence from systematic reviews and meta-analyses informing the 2023 EULAR/PReS recommendations for the diagnosis and management of Still's disease
Ann Rheum Dis
De Matteis A, Bindoli S, De Benedetti F, Carmona L, Fautrel B, Mitrovic S
doi: 10.1136/ard-2024-225853
Further Publications Rheumatology
The clinical assessment of lung involvement in patients with Still's disease, results from the multicentre international AIDA Network Still's Disease Registry
Rheumatology (Oxford)
Ruscitti P, Vitale A, Di Cola I, Caggiano V, Palumbo P, Di Cesare E, Hinojosa-Azaola A, Torres-Ruiz J, Guaracha-Basañez GA, Martín-Nares E, Lopalco G, Morrone M, Iannone F, Giardini HAM, Cordeiro RA, de Brito Antonelli IP, Berardicurti O, Navarini L, Ciccia F, Visconti MC, Iacono D, Direskeneli H, Erten S, Yao H, Thabet M, Tharwat S, Ragab G, Gómez-Caverzaschi V, Sfikakis PP, Fotis L, La Torre F, Maier A, Karamanakos A, Almaghlouth IA, Frassi M, Tufan A, Govoni M, Sota J, Simonini G, Emmi G, Li Gobbi F, Parronchi P, Costi S, Sarzi-Puttini P, Opris-Belinski D, Sfriso P, Tarsia M, Maggio MC, Monti S, Gündüz ÖS, Rigante D, Bartoloni E, Verrecchia E, Iagnocco A, Viapiana O, Bargagli E, Batu ED, Sebastiani GD, Del Giudice E, Conti G, Breda L, Gidaro A, Gicchino MF, Gaggiano C, Brucato AL, Triggianese P, Makowska J, Carubbi F, Farina N, Guggino G, De Paulis A, Mazzei MA, Di Meglio N, Lo Gullo A, Conforti A, Ogunjimi B, Calabrese L, Rubegni P, Giardina A, Wiesik-Szewczyk E, Balistreri A, Fabiani C, Frediani B, Dagna L, Giacomelli R, Cantarini L
doi: 10.1093/rheumatology/keaf021
Autoimmune Disease
The evaluation of myocarditis in patients with Still's disease; clinical findings from the multicentre international AIDA Network Still's Disease Registry
J Rheumatol
Ruscitti P, Di Cola I, Vitale A, Caggiano V, Palumbo P, Di Cesare E, Torres-Ruiz J, Guaracha-Basañez GA, Martín-Nares E, Ciccia F, Iacono D, Riccio F, Maggio MC, Tharwat S, Hashad S, Rigante D, Ortolan A, Giardini HAM, Parente de Brito Antonelli I, Cordeiro RA, Giacomelli R, Navarini L, Berardicurti O, Conforti A, Opris-Belinski D, Sota J, Gaggiano C, Lopalco G, Iannone F, La Torre F, Mastrorilli V, Govoni M, Ruffilli F, Emmi G, Biancalana E, Sfikakis PP, Tektonidou M, Hernández-Rodríguez J, Gómez-Caverzaschi V, Gündüz ÖS, Conti G, Patroniti S, Gidaro A, Bartoli A, Olivieri AN, Gicchino MF, Brucato AL, Dagna L, Tomelleri A, Campochiaro C, De Paulis A, Mormile I, Della Casa F, Direskeneli H, Alibaz-Oner F, Karamanakos A, Dimouli A, Ragab G, Mahmoud Ahmed AA, Tufan A, Kucuk H, Kardas R, Batu ED, Ozen S, Wiesik-Szewczyk E, Hinojosa-Azaola A, Balistreri A, Fabiani C, Frediani B, Cantarini L
doi: 10.3899/jrheum.2024-0683
Further Publications Rheumatology
Efficacy and safety of infliximab or adalimumab in severe mucocutaneous Behçet's syndrome refractory to traditional immunosuppressants: a 6-month, multicentre, randomised controlled, prospective, parallel group, single-blind trial
Ann Rheum Dis
Talarico R, Italiano N, Emmi G, Piga M, Cantarini L, Mattioli I, Floris A, Gentileschi S, Di Cianni F, Urban ML, Chiara E, Marinello D, Del Bianco A, Figus M, Posarelli C, Fabiani C, Vagnani S, Andreozzi G, Lorenzoni V, Turchetti G, Cauli A, Emmi L, Salvarani C, Della Casa Alberighi O, Bombardieri S, Mosca M
doi: 10.1136/ard-2024-226113
Autoimmune Disease
Mortality in patients with Sjögren Disease: A Prospective Cohort Study Identifying Key Predictors
J Rheumatol
Lovgach OR, Plaza Z, Fernández Castro M, Rosas J, Martínez-Taboada V, Olivé A, Menor Almagro R, Serrano Benavente B, Font-Urgelles J, Garcia-Aparicio A, Manrique-Arija S, Garcia-Vadillo JA, Lopez-Gonzalez R, Narvaez García J, Rodriguez-Lozano MB, Galisteo C, Gonzalez-Martin JJ, Vela-Casasempere P, Bohorquez C, Erausquin C, Paredes-Romero MB, Riancho-Zarrabeitia L, Diaz SM, Pego-Reigosa JM, Heredia S, Moriano C, Blazquez Cañamero MA, Estrada P, Judez E, Belzunegui Otano J, Ramos Giráldez C, Domínguez Álvaro M, Sánchez Alonso F, Andréu Sánchez JL
doi: 10.3899/jrheum.2024-1033